Emerging dominant SARS-CoV-2 variants
Jiahui Chen, Rui Wang, Yuta Hozumi, Gengzhuo Liu, Yuchi, Qiu, Xiaoqi Wei, Guo-Wei Wei

TL;DR
This paper presents AI models integrating biophysics, genotyping, experimental data, algebraic topology, and deep learning to forecast emerging SARS-CoV-2 variants, aiding preparedness for future infection waves.
Contribution
It introduces a novel AI framework that accurately predicts dominant SARS-CoV-2 variants using multidisciplinary data and analysis of viral mutations and evolution.
Findings
Forecasted Omicron variants BA.1, BA.2, BA.4/BA.5 accurately
Identified potential new dominant variants BA.2.75+R346T and others
Analyzed viral evolution mechanisms through infectivity and antibody resistance
Abstract
Accurate and reliable forecasting of emerging dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants enables policymakers and vaccine makers to get prepared for future waves of infections. The last three waves of SARS-CoV-2 infections caused by dominant variants Omicron (BA.1), BA.2, and BA.4/BA.5 were accurately foretold by our artificial intelligence (AI) models built with biophysics, genotyping of viral genomes, experimental data, algebraic topology, and deep learning. Based on newly available experimental data, we analyzed the impacts of all possible viral spike (S) protein receptor-binding domain (RBD) mutations on the SARS-CoV-2 infectivity. Our analysis sheds light on viral evolutionary mechanisms, i.e., natural selection through infectivity strengthening and antibody resistance. We forecast that BA.2.10.4, BA.2.75, BQ.1.1, and particularly, BA.2.75+R346T,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · vaccines and immunoinformatics approaches · COVID-19 Clinical Research Studies
